Cargando…

Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants

Vaccines are considered one of the greatest medical achievements in the battle against infectious diseases. However, the intractability of various diseases such as hepatitis C, HIV/AIDS, malaria, tuberculosis, and cancer poses persistent hurdles given that traditional vaccine-development methods hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lebel, Marie-Ève, Chartrand, Karine, Leclerc, Denis, Lamarre, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586470/ https://www.ncbi.nlm.nih.gov/pubmed/26350598 http://dx.doi.org/10.3390/vaccines3030620

Ejemplares similares

Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference
por: Chartrand, Karine, et al.
Publicado: (2018)

Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles
por: Savard, Christian, et al.
Publicado: (2011)

Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy
por: Nikitin, Nikolai, et al.
Publicado: (2023)

Polyethylenimine-based micro/nanoparticles as vaccine adjuvants
por: Shen, Chen, et al.
Publicado: (2017)

Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines
por: Filipić, Brankica, et al.
Publicado: (2023)

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age
por: Langley, Joanne, et al.
Publicado: (2020)

Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine
por: Rioux, Gervais, et al.
Publicado: (2016)

Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
por: Alfagih, Iman M., et al.
Publicado: (2020)

PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
por: Rioux, Gervais, et al.
Publicado: (2014)

Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting
por: Gutjahr, Alice, et al.
Publicado: (2016)

A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus
por: Li, Jianping, et al.
Publicado: (2018)

A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling
por: Thérien, Ariane, et al.
Publicado: (2017)

Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant
por: Kovalenko, Angelina O., et al.
Publicado: (2022)

Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study
por: Rungrojcharoenkit, Kamonthip, et al.
Publicado: (2020)

Polyethylenimine-based micro/nanoparticles as vaccine adjuvants [Corrigendum]
Publicado: (2017)

Plant-based vaccines against viruses
por: Rybicki, Edward P
Publicado: (2014)

Repurposing Plant Virus Nanoparticles
por: Hefferon, Kathleen L.
Publicado: (2018)

Nanoparticle-Based Vaccines Against Respiratory Viruses
por: Al-Halifa, Soultan, et al.
Publicado: (2019)

Design and application of nanoparticles as vaccine adjuvants against human corona virus infection
por: Mao, Lichun, et al.
Publicado: (2021)

Adjuvants for peptide-based cancer vaccines
por: Khong, Hiep, et al.
Publicado: (2016)

A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles
por: Liu, Ze-Hui, et al.
Publicado: (2022)

Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination
por: Zhang, Lei, et al.
Publicado: (2018)

Neonatal vaccine effectiveness and the role of adjuvants
por: Sakala, Isaac G., et al.
Publicado: (2019)

Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity
por: Laliberté-Gagné, Marie-Eve, et al.
Publicado: (2021)

Plant Virus Nanoparticles Combat Cancer
por: Shahgolzari, Mehdi, et al.
Publicado: (2023)

Micelle-Based Adjuvants for Subunit Vaccine Delivery
por: Trimaille, Thomas, et al.
Publicado: (2015)

An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
por: Petkar, Kailash C., et al.
Publicado: (2021)

Aluminum-based metal–organic framework nanoparticles as pulmonary vaccine adjuvants
por: Stillman, Zachary S., et al.
Publicado: (2023)

ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES
por: Friedewald, William F.
Publicado: (1944)

Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States
por: Boikos, Constantina, et al.
Publicado: (2022)

Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP
por: Babin, Cindy, et al.
Publicado: (2013)

Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus
por: Kumar, Arbind, et al.
Publicado: (2022)

Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis
por: Santos Júnior, Samuel Rodrigues Dos, et al.
Publicado: (2023)

Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants
por: Sepulveda-Crespo, Daniel, et al.
Publicado: (2020)

Prospects for the Use of Metal-Based Nanoparticles as Adjuvants for Local Cancer Immunotherapy
por: Naletova, Irina, et al.
Publicado: (2023)

Promising Plant-Derived Adjuvants in the Development of Coccidial Vaccines
por: Sander, Valeria A., et al.
Publicado: (2019)

Chemokines as Cancer Vaccine Adjuvants
por: Bobanga, Iuliana D., et al.
Publicado: (2013)

Vaccine Potentiation by Combination Adjuvants
por: Levast, Benoît, et al.
Publicado: (2014)

Adjuvants for COVID-19 Vaccines
por: Castrodeza-Sanz, Javier, et al.
Publicado: (2023)

Advances in Adjuvanted Influenza Vaccines
por: Shichinohe, Shintaro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g48424vltuh074m02hftjb2h8t